CC
PMD

Cannell Capital’s Psychemedics Corporation PMD Stock Holding History

Cannell Capital’s Portfolio PMD Stock Details PMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-74,794
Closed -$297K – 61
2023
Q3 		$297K Hold
74,794
– – 0.07% 49
2023
Q2 		$341K Hold
74,794
– – 0.07% 53
2023
Q1 		$393K Hold
74,794
– – 0.08% 56
2022
Q4 		$367K Sell
74,794
-14,417
-16% -$85K 0.07% 51
2022
Q3 		$575K Hold
89,211
– – 0.13% 52
2022
Q2 		$566K Buy
89,211
+10,905
+14% +$69.9K 0.11% 51
2022
Q1 		$540K Buy
78,306
+7,306
+10% +$51.7K 0.08% 53
2021
Q4 		$498K Buy
+71,000
New +$568K 0.08% 56

Other funds holding PMD

2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CIC
Crawford Investment Counsel Atlanta, Georgia $5.85B AUM 12.61% 1-Year Est. Return

Cannell Capital's PMD Position: Q4 2023 in Review

Cannell Capital sold out of Psychemedics Corporation (PMD) in Q4 2023, closing a stake of 74,794 shares — an estimated $297K sold.

Cannell Capital first reported a position in PMD in Q4 2021 and held it in 8 quarters. The position peaked at $575K in Q3 2022. 23 funds tracked by Wall St. Rank hold PMD as of Q4 2023.

  • Cannell Capital reported no remaining Psychemedics Corporation position as of Q4 2023 after selling out during the quarter.
  • Cannell Capital sold 74,794 Psychemedics Corporation shares in Q4 2023, an estimated $297K.
  • Cannell Capital first reported a position in Psychemedics Corporation in Q4 2021 and held it in 8 quarters.
  • Cannell Capital's Psychemedics Corporation position peaked at $575K in Q3 2022.
  • 23 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q4 2023.

Based on Cannell Capital's 13F filing for Q4 2023, filed 14 Feb 2024.